NeuroBo Pharmaceuticals, Inc. Annual Depreciation in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
NeuroBo Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2019 to 2023.
  • NeuroBo Pharmaceuticals, Inc. Depreciation for the quarter ending September 30, 2024 was $5K, a 400% increase year-over-year.
  • NeuroBo Pharmaceuticals, Inc. annual Depreciation for 2023 was $6K, a 70% decline from 2022.
  • NeuroBo Pharmaceuticals, Inc. annual Depreciation for 2022 was $20K, a 58.3% decline from 2021.
  • NeuroBo Pharmaceuticals, Inc. annual Depreciation for 2021 was $48K, a 4.35% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6K -$14K -70% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $20K -$28K -58.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $48K +$2K +4.35% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $46K +$29K +171% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $17K Jan 1, 2019 Dec 31, 2019 10-K 2021-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.